The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats

Drug Development Research

Volumn 56, Issue 1, 2002, Pages 23-32

  Ghelardini, Carla ^a,b   Galeotti, Nicoletta ^a   Gualtieri, Fulvio ^a   Manetti, Dina ^a   Bucherelli, Corrado ^a   Baldi, Elisabetta ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Pharmacology ^*  (Italy)

Author keywords

Learning and memory; Morris water maze; Nootropic drug; Passive avoidance; Social learning

Indexed keywords

4 [4 (FLUOROBENZENESULFONYL)] 1,4 DIAZABICYCLO[4.3.0]NONAN 9 ONE; ANIRACETAM; BACLOFEN; CLONIDINE; DM 232; MECAMYLAMINE; NICOTINE; NOOTROPIC AGENT; PENTOBARBITAL; PIRACETAM; ROLIPRAM; SCOPOLAMINE; UNCLASSIFIED DRUG; UNIFIRAM;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; RAT;

EID: 0036321317     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10055     Document Type: Article

References (40)

1. The cholinergic hypothesis of geriatric memory dysfunctions
2. Muscarinic receptors: Characterization, coupling and function
3. Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment
4. A cholinergic hypothesis for Alzheimer's disease
5. Long-term and high-dose piracetam treatment of Alzheimer's disease
6. Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats
7. Amnesia produced by intracerebroventricular injections of hemicolinium-3 in mice was prevented by pretreatment with piracetam-like compounds
8. Amnesic actions of diazepam and scopolamine in man
9. Effects of funarizine and nitrendipine on electroconvulsive shock- and clonidine-induced amnesia
10. Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine
11. Piracetam and other structurally related nootropics
12. Facilitation of memory and cognition by drugs
13. Alzheimer's disease is it worth treating?
14. An improved one-trial passive avoidance learning situation
15. A receptor agonist, muscimol, on the role of the entorhinal cortex, amygdala, and hippocampus in memory processes
16. Scopolamine effects on Hamilton search task performance in monkeys
17. Design, synthesis, and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents
18. Molecular simplification of 1,4-diazabicyclo[4.3.0.]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity
19. Dissociation learning and performance: Drug and hormone enhancement of memory storage
20. How long does "memory consolidation" take? New compounds can improve retention performance, even if administered up to 24 h after the learning experience
21. B receptor blocker improves the cognitive performance of mice, rats and rhesus monkeys
22. Developments of a water-maze procedure for studying spatial learning in the rat
23. Piracetam: Novelty in a unique mode of action
24. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia
25. Piracetam improves visuo-motor and cognitive deficits in early Parkinsonism: A pilot study
26. Action of nootropic drugs on transcallosal responses in rats
27. Historical context of state dependent learning and discriminative drug effects
28. Cognitive enhancement therapy for Alzheimer's disease
29. Effect of nootropic agents on brain cholinergic mechanism
30. Nootropic drugs and brain cholinergic mechanism
31. Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice
32. Effect of the cognition enhancing agent oxiracetam on electrical activity of hippocampal slices
33. Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat
34. Taking stock of cognition enhancer
35. Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices
36. Baclofen disrupts passive avoidance retention in rats
37. Effects of aniracetam on one-trial passive avoidance test and cholinergic neurones in discrete brain regions of rats
38. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen
39. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders
40. Comparative studies on the influence of ONK(N(5-hydroxynicotinoil)glutamic acid), piracetam and meclofenoxate on the learning- and memory-impairing effect of scopolamine, clonidine and methergoline